Global Hypercholesterolemia Treatment Market – Industry Trends and Forecast to 2030

Global Hypercholesterolemia Treatment Market, By Treatment (Diagnosis, Medication, Physical Therapy, Others), Drug Type (Branded, Generics), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.

Hypercholesterolemia Treatment Market Analysis and Size

The hypercholesterolemia treatment market is anticipated to witness major growth during the forecast period. Growing cases of hypertension, cardiomyopathy, and diabetes increase market growth. Factors such as adaptation to unhealthy lifestyles, increased stress in daily life & malnutrition, and family history of cardiac disease is also growing the market growth. Several major market players are contributing a lot to drug discovery and development.

Data Bridge Market Research analyses a growth rate in the hypercholesterolemia treatment market in the forecast period 2023-2030. The expected CAGR of hypercholesterolemia treatment market tends to be around 16.2% in the mentioned forecast period. The market was valued at USD 15.05 billion in 2022 and would grow to USD 50.02 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Hypercholesterolemia Treatment Market Scope and Segmentation

Market Definition

Hypercholesterolemia treatment is used to treat the excessive amount of cholesterol is present in the blood. As per a latest research, number of homozygous familial hypercholesterolemia clinical studies conducted globally increased by 93% between 2016 and 2020. Hypercholesterolemia is increased by unhealthy eating, underrated thyroid level, and other chronic diseases such as diabetes, heart diseases, and many others. Hypercholesterolemia is a severe life-threatening condition wherein the treatment are used to decline the level of bad cholesterol in the blood.

Hypercholesterolemia Treatment Market Dynamics

Drivers

• Increase in Hypercholesterolemia

As per the World Health Organization (WHO), hypercholesterolemia is estimated to result in more than 2.6 million deaths yearly. About 37.0% of adults in the U.S. have increased LDL-C levels. Yet, less than 50.0% of patients who receive any type of treatment and around 33.0% of patients undergoing treatment cannot obtain normal lipid levels. Therefore, it boosts the demand in the hypercholesterolemia treatment market.

• Increased Clinical Studies and Government Initiatives

According to estimates, the market is being pushed by the rising R&D expenditures for drug discovery and development as well as the rising prevalence of diabetes. For instance, the International Diabetes Federation reports that there are currently 642 million diabetics worldwide, with the number expected to rise to 415 million by the year 2040 if diabetes is treated as a form of the metabolic syndrome. Consequently, the market is growing as a result of these increased clinical efforts.

Opportunities

• Growing Demand for Statins

Statins are recommended because of numerous advantages such as enhanced endothelial function, decreased oxidative stress-induced cell damage, increased atherosclerotic plaque stability, and reduced inflammation. In addition to this, PCSK9 inhibitors are anticipated to surge in popularity during the forecast period because of the sharp decline in blood LDL levels.

• Increasing Demand for Drug Therapy

Due to its broad usage, simplicity of administration, and high rate of reliability, drug therapy is driving the industry. Despite the fact that this therapy uses cutting-edge methods to provide medications without interfering with patients' daily lives, it is anticipated that it will continue to grow. Moreover, it is projected that the introduction of intelligent drug delivery systems and intelligent dosage control techniques would further expand the market.

Restraints/Challenges

• Lack of Skilled Professionals

A lack of trained healthcare professionals who are not aware of the appropriate treatment methods for this disease could decrease the growth of the global hypercholesterolemia treatment market during a forecast period.

• Adverse Side-Effects Associated with Hypercholesterolemia treatment

The majority of treatments for hypercholesterolemia are associated with side effects like type 2 diabetes or liver damage. Even in the later stages of trials, drug classes like CETP inhibitors have been withdrawn or discontinued because of side effects or an inability to produce satisfactory results. Antihyperlipidemic medications come with a number of risks, which make it difficult for them to enter the market.

This hypercholesterolemia treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the hypercholesterolemia treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Hypercholesterolemia Treatment Market Scope

The hypercholesterolemia treatment market is segmented on the basis of, treatment, drug type, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

• Medication
• Physical Therapy
• Others

Drug Type

• Branded
• Generics

Route of Administration

• Oral
• Parenteral
• Others

End-Users

• Hospitals
• Homecare
• Speciality Centres
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Hypercholesterolemia Treatment Market Regional Analysis/Insights

The hypercholesterolemia treatment market is analyzed and market size insights and trends are provided by, treatment, drug type, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the hypercholesterolemia treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to have the highest market due to the increased incidence of hypercholesterolemia because around 28.5 million adults or nearly 12% of the adult population in the U.S. have total cholesterol levels ≥240 mg/dL.

Asia-Pacific dominates the market due to increased technological advancements as well as growing healthcare expenditure.  

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Hypercholesterolemia Treatment Market Share Analysis

The hypercholesterolemia treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to hypercholesterolemia treatment market.

Key players operating in the hypercholesterolemia treatment market include:

• Pfizer Inc. (U.S.)
• Novartis AG (Switzerland)
• Amgen Inc. (U.S.)
• Boehringer Ingelheim International GmbH. (Germany)
• Merck & Co Inc. (U.S.)
• Sun Pharmaceutical Industries Ltd. (India)
• Teva Pharmaceuticals Industries Ltd. (Israel)
• AstraZeneca (U.K.)
• Fresenius Kabi AG (Germany)
• Bayer AG (Germany)
• Aurobindo Pharma (India)
• AbbVie Inc. (U.S.)
• Melinta Therapeutics, Inc (U.S.)